Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",A1BG,Alpha-1B-glycoprotein,16032,63,4.50 [1.05-19.24],0.0422660640693088
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AARSD1,Alanyl-tRNA editing protein Aarsd1,18344,71,1.91 [1.35-2.68],0.0002116662955099
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ABL1,Tyrosine-protein kinase ABL1,18344,71,1.45 [1.10-1.92],0.0089253882196162
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACP6,Lysophosphatidic acid phosphatase type 6,18583,70,1.50 [1.04-2.16],0.0291039761381265
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACVRL1,Serine/threonine-protein kinase receptor R3,18250,71,2.64 [1.26-5.54],0.0100217491046192
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,15485,61,1.57 [1.06-2.32],0.0250882367002895
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,18109,70,2.94 [1.52-5.70],0.0013688567477734
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,18284,71,1.87 [1.05-3.33],0.0338833004296725
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,18567,71,13.34 [5.63-31.60],3.877133794828786e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,15956,64,3.20 [1.76-5.81],0.0001384788163701
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADGRE1,Adhesion G protein-coupled receptor E1,15956,64,1.76 [1.18-2.62],0.0054084479682063
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADGRE2,Adhesion G protein-coupled receptor E2,18492,70,3.98 [2.15-7.36],1.0921842038447618e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADGRE5,Adhesion G protein-coupled receptor E5,18572,71,2.90 [2.05-4.11],2.2468739483169957e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AFP,Alpha-fetoprotein,18216,70,1.52 [1.11-2.09],0.0088240849431908
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AHNAK,Neuroblast differentiation-associated protein AHNAK,15560,59,4.56 [3.16-6.58],5.365531643133178e-16
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AKAP12,A-kinase anchor protein 12,15659,64,2.25 [1.05-4.81],0.0359141638740512
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ALCAM,CD166 antigen,18663,72,10.17 [4.04-25.63],8.619623672826231e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",15987,64,1.85 [1.23-2.78],0.0029318451037937
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ALPI,Intestinal-type alkaline phosphatase,15528,61,0.79 [0.64-0.98],0.0329415481101805
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AMPD3,AMP deaminase 3,15980,64,1.60 [1.16-2.21],0.0038760002832065
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,15560,59,0.31 [0.12-0.84],0.0206664781899321
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANXA2,Annexin A2,15336,58,1.89 [1.55-2.29],1.6466948757496175e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,18344,71,1.95 [1.46-2.59],4.896092737505665e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,18555,70,2.94 [2.37-3.65],1.3449875722897561e-22
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APOE,Apolipoprotein E,16032,63,1.28 [1.01-1.61],0.0408418907881541
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APP,Amyloid-beta precursor protein,18408,70,0.71 [0.51-0.99],0.0452965158634518
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APRT,Adenine phosphoribosyltransferase,18253,70,2.10 [1.29-3.41],0.002806538961675
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARG1,Arginase-1,18330,69,1.51 [1.00-2.26],0.0480942300395552
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARHGAP25,Rho GTPase-activating protein 25,18014,68,1.90 [1.52-2.38],1.94575533579984e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARID4B,AT-rich interactive domain-containing protein 4B,18039,70,2.04 [1.64-2.53],1.8181905638829016e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ARTN,Artemin,18124,68,1.42 [1.05-1.92],0.0221046955727372
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ASPN,Asporin,16007,62,0.30 [0.12-0.79],0.0140321639242525
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATP5PO,"ATP synthase subunit O, mitochondrial",18039,70,1.43 [1.10-1.87],0.0077079444205697
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATRAID,All-trans retinoic acid-induced differentiation factor,15956,64,2.13 [1.49-3.03],2.889340574241879e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ATRN,"Attractin, Isoform 2",16032,63,5.13 [1.31-20.05],0.0187275579352005
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AZI2,5-azacytidine-induced protein 2,15987,64,1.67 [1.15-2.43],0.0072213790614535
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",B2M,Beta-2-microglobulin,16032,63,1.69 [1.25-2.29],0.0006665950688287
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",B4GALT1,"Beta-1,4-galactosyltransferase 1",18492,70,12.54 [7.50-20.97],5.152099419985515e-22
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BAG4,BAG family molecular chaperone regulator 4,15528,61,2.03 [1.46-2.83],2.8851718543464063e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BAG6,Large proline-rich protein BAG6,18109,70,1.74 [1.00-3.03],0.0491192634110389
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BANK1,B-cell scaffold protein with ankyrin repeats,18427,71,1.24 [1.01-1.53],0.0403127378639556
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BAP18,Chromatin complexes subunit BAP18,15980,64,1.92 [1.67-2.20],1.3450014215564091e-20
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BCL2,Apoptosis regulator Bcl-2,15956,64,2.53 [2.15-2.97],1.289229127561338e-29
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BDNF,Brain-derived neurotrophic factor,16018,64,0.68 [0.52-0.89],0.0044021298289202
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BECN1,Beclin-1,15560,59,1.61 [1.10-2.35],0.014301976746882
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BGN,Biglycan,17988,68,1.19 [1.00-1.42],0.0474597015667879
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BHLHE40,Class E basic helix-loop-helix protein 40,15523,61,0.62 [0.43-0.89],0.008546751859954
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BLNK,B-cell linker protein,15528,61,3.48 [2.94-4.10],5.544448011559757e-49
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,15528,61,3.06 [2.22-4.21],6.930347308297421e-12
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BOLA1,BolA-like protein 1,15523,61,1.49 [1.05-2.10],0.0237688526767839
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BSG,Basigin,18620,71,3.70 [1.42-9.65],0.0074714878724361
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BST2,Bone marrow stromal antigen 2,18597,71,1.71 [1.25-2.35],0.0008894872487909
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BTN2A1,Butyrophilin subfamily 2 member A1,18492,70,4.02 [2.14-7.56],1.558795467338003e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BTN3A2,Butyrophilin subfamily 3 member A2,18427,71,2.10 [1.37-3.22],0.0006330338305859
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C1QA,Complement C1q subcomponent subunit A,18562,71,3.03 [1.32-6.95],0.0089205770972143
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C1QL2,Complement C1q-like protein 2,15528,61,0.45 [0.24-0.86],0.0154765494549251
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C1RL,Complement C1r subcomponent-like protein,15997,63,7.84 [2.33-26.39],0.0008755530253769
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C7orf50,Uncharacterized protein C7orf50,15980,64,3.27 [2.60-4.10],2.287492947519362e-24
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,15560,59,1.55 [1.13-2.12],0.0059833336843299
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CANT1,Soluble calcium-activated nucleotidase 1,18369,70,19.40 [7.42-50.71],1.4542729701687543e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CAPG,Macrophage-capping protein,18320,70,1.80 [1.34-2.42],8.297215696145679e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CASP4,Caspase-4,15731,62,0.76 [0.62-0.93],0.0067225053986088
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CASQ2,Calsequestrin-2,15485,61,0.34 [0.15-0.76],0.0081823946543139
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CBLIF,Cobalamin binding intrinsic factor,18412,70,0.71 [0.57-0.89],0.0028908390383708
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCAR2,Cell cycle and apoptosis regulator protein 2,15980,64,1.39 [1.08-1.80],0.0114399154847185
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCDC50,Coiled-coil domain-containing protein 50,15987,64,1.68 [1.43-1.97],3.633429720032063e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL17,C-C motif chemokine 17,18374,70,0.74 [0.59-0.94],0.0128881860729943
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL3,C-C motif chemokine 3,18427,71,1.60 [1.38-1.85],3.262106066475151e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL4,C-C motif chemokine 4,18434,70,1.37 [1.10-1.72],0.0058075932419299
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL5,C-C motif chemokine 5,18520,69,0.73 [0.59-0.89],0.0024962887186498
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCN1,CCN family member 1,18318,71,0.68 [0.52-0.89],0.004601083437157
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCN2,CCN family member 2,18417,69,0.52 [0.35-0.78],0.0013669238029872
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCND2,G1/S-specific cyclin-D2,15731,62,3.44 [1.69-6.98],0.0006417215465837
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD14,Monocyte differentiation antigen CD14,18094,67,2.00 [1.24-3.23],0.0047385686817186
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD163,Scavenger receptor cysteine-rich type 1 protein M130,18520,69,2.02 [1.29-3.17],0.0022305979548872
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD177,CD177 antigen,18400,70,1.32 [1.09-1.60],0.0037846973346351
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD1C,T-cell surface glycoprotein CD1c,18477,72,3.27 [1.38-7.78],0.0072351497637233
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD200,OX-2 membrane glycoprotein,18427,71,4.95 [3.98-6.14],2.6602143002628653e-47
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD200R1,Cell surface glycoprotein CD200 receptor 1,18361,71,1.82 [1.05-3.16],0.0337893145688333
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD22,B-cell receptor CD22,18653,71,3.79 [3.01-4.76],3.1342275574121703e-30
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD27,CD27 antigen,18477,72,7.05 [5.21-9.52],5.390237159785394e-37
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD274,Programmed cell death 1 ligand 1,18284,71,1.83 [1.07-3.16],0.0286531190971531
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD28,T-cell-specific surface glycoprotein CD28,18014,68,2.38 [1.84-3.07],3.031647528605997e-11
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD300A,CMRF35-like molecule 8,15659,64,2.71 [1.33-5.52],0.0059051299478284
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD300C,CMRF35-like molecule 6,18597,71,2.32 [1.33-4.05],0.0030507110174566
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD300LF,CMRF35-like molecule 1,18606,70,1.60 [1.08-2.38],0.0204589535513504
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD40LG,CD40 ligand,18653,71,0.73 [0.56-0.94],0.0158092274845983
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD46,Membrane cofactor protein,18352,68,3.38 [1.99-5.71],5.851482143820566e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD48,CD48 antigen,18471,70,20.23 [13.49-30.34],5.928745916623256e-48
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD5,T-cell surface glycoprotein CD5,18580,70,4.96 [4.16-5.92],2.000473217231505e-70
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD59,CD59 glycoprotein,17792,67,2.71 [1.31-5.62],0.00746634709894
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD5L,CD5 antigen-like,15963,62,0.40 [0.24-0.68],0.0006961360177797
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD6,T-cell differentiation antigen CD6,18620,71,5.60 [3.98-7.88],5.808791068616979e-23
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD63,CD63 antigen,18250,71,0.64 [0.42-0.96],0.0315038152939619
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD7,T-cell antigen CD7,15501,61,1.64 [1.01-2.65],0.0433621738862532
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD70,CD70 antigen,18427,71,5.70 [4.53-7.17],5.126821329636285e-50
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD72,B-cell differentiation antigen CD72,15659,64,7.74 [5.90-10.17],4.535583433443921e-49
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD74,HLA class II histocompatibility antigen gamma chain,18597,71,10.70 [7.32-15.64],2.161029121393215e-34
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD79B,B-cell antigen receptor complex-associated protein beta chain,18653,71,6.35 [5.18-7.79],1.646843146246969e-70
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD80,T-lymphocyte activation antigen CD80,16007,62,7.68 [5.44-10.85],5.69947617209877e-31
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD82,CD82 antigen,15731,62,0.42 [0.18-0.96],0.0407823696305926
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD83,CD83 antigen,18427,71,5.97 [3.74-9.54],8.127691696299649e-14
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD86,T-lymphocyte activation antigen CD86,15956,64,4.22 [2.31-7.74],3.0466823600601253e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD8A,T-cell surface glycoprotein CD8 alpha chain,18597,71,1.85 [1.33-2.59],0.0002885975994763
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDC27,Cell division cycle protein 27 homolog,18014,68,1.51 [1.12-2.04],0.0075056043785908
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDCP1,CUB domain-containing protein 1,18284,71,1.44 [1.02-2.03],0.0380343866536472
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDH15,Cadherin-15,18569,71,0.68 [0.48-0.95],0.0261758316076369
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDH17,Cadherin-17,18432,70,0.64 [0.46-0.90],0.0109198189110379
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDH3,Cadherin-3,18597,71,3.58 [2.21-5.81],2.395469617900915e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDK1,Cyclin-dependent kinase 1,15454,61,2.76 [1.49-5.11],0.0012086237406369
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,18450,72,3.80 [1.49-9.67],0.0051089853827106
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,16018,64,0.44 [0.23-0.84],0.0133385211806094
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEP164,Centrosomal protein of 164 kDa,18124,68,1.29 [1.02-1.62],0.0304995047972796
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEP43,Centrosomal protein 43,17969,70,1.42 [1.06-1.90],0.0186561855291234
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CEP85,Centrosomal protein of 85 kDa,18014,68,1.53 [1.17-2.02],0.0022989715260828
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CGA,Glycoprotein hormones alpha chain,18432,70,1.40 [1.03-1.91],0.0303137746540075
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CHAD,Chondroadherin,15659,64,0.41 [0.25-0.67],0.0003165205876647
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",15980,64,2.62 [2.00-3.45],4.103807820646019e-12
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CHCHD6,MICOS complex subunit MIC25,15951,63,2.37 [1.38-4.08],0.001863611689148
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CHL1,Neural cell adhesion molecule L1-like protein,18493,69,1.97 [1.04-3.74],0.0376787318778955
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CIT,Citron Rho-interacting kinase,15599,60,1.66 [1.13-2.44],0.0092873107495462
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CKAP4,Cytoskeleton-associated protein 4,18562,71,3.46 [2.55-4.68],9.891409404142223e-16
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLC,Galectin-10,18403,70,0.71 [0.50-1.00],0.0495506916698411
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLEC11A,C-type lectin domain family 11 member A,18404,70,0.60 [0.39-0.93],0.0206388361534399
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLEC12A,C-type lectin domain family 12 member A,15528,61,4.16 [2.68-6.47],2.2054360888742158e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLEC1A,C-type lectin domain family 1 member A,18109,70,2.11 [1.18-3.77],0.0117097398379721
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLEC4C,C-type lectin domain family 4 member C,18427,71,2.91 [2.05-4.13],2.1429405609701754e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLSTN3,Calsyntenin-3,15980,64,4.16 [2.65-6.52],5.144209748852256e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLU,Clusterin,16032,63,1.64 [1.04-2.59],0.0345837578080481
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CNTN1,Contactin-1,18663,72,2.24 [1.02-4.89],0.0437363770321281
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CNTNAP2,Contactin-associated protein-like 2,18427,71,1.94 [1.25-3.02],0.0030502037461239
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COCH,Cochlin,16007,62,3.51 [2.38-5.17],2.0743647935477384e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COL18A1,Collagen alpha-1(XVIII) chain,18506,70,2.88 [1.20-6.90],0.017825942205207
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COL4A1,Collagen alpha-1(IV) chain,18432,70,2.05 [1.27-3.32],0.0032489017067294
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COL9A2,Collagen alpha-2(IX) chain,15731,62,1.84 [1.44-2.36],1.4275645663278277e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",15560,59,1.58 [1.06-2.35],0.0235080215726169
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CPXM1,Probable carboxypeptidase X1,18477,72,0.67 [0.49-0.91],0.011465476670466
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CR1,Complement receptor type 1,15972,63,3.46 [1.90-6.32],5.238228556933279e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CR2,Complement receptor type 2,18520,69,3.31 [2.24-4.89],1.7280881808983975e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRH,Corticoliberin,17988,68,1.95 [1.56-2.43],4.1186510624004755e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRIM1,Cysteine-rich motor neuron 1 protein,18492,70,4.66 [1.82-11.93],0.0013450617982985
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRISP3,Cysteine-rich secretory protein 3,15875,64,0.53 [0.30-0.95],0.0325971552171828
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRLF1,Cytokine receptor-like factor 1,18492,70,7.32 [3.24-16.55],1.724007642037617e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRTAM,Cytotoxic and regulatory T-cell molecule,18284,71,4.51 [3.18-6.39],2.239994398991996e-17
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CSF1,Macrophage colony-stimulating factor 1,18492,70,5.41 [2.78-10.53],6.713668960905128e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CSF1R,Macrophage colony-stimulating factor 1 receptor,16029,64,2.23 [1.50-3.32],7.100209021730193e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CSTB,Cystatin-B,18182,70,1.89 [1.25-2.87],0.0027116897315227
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTSL,Cathepsin L1,18432,70,4.15 [1.97-8.71],0.0001733763199983
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTSS,Cathepsin S,14555,62,3.75 [1.42-9.87],0.0074264052161295
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CTSV,Cathepsin L2,18536,69,0.51 [0.29-0.90],0.0206078263225966
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CWC15,Spliceosome-associated protein CWC15 homolog,15864,63,2.11 [1.77-2.51],2.6933971890506402e-17
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CXCL13,C-X-C motif chemokine 13,18597,71,1.52 [1.27-1.82],5.95122908657249e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CXCL3,C-X-C motif chemokine 3,18413,70,0.74 [0.60-0.91],0.0052541274764875
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CXCL5,C-X-C motif chemokine 5,18370,70,0.75 [0.63-0.91],0.0025767619216036
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CXCL9,C-X-C motif chemokine 9,18492,70,1.44 [1.10-1.88],0.0076761105791536
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CYB5R2,NADH-cytochrome b5 reductase 2,15792,64,3.43 [2.70-4.35],4.110714276100687e-24
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",15485,61,0.53 [0.33-0.85],0.0081793552582483
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DBI,Acyl-CoA-binding protein,18344,69,1.43 [1.10-1.86],0.0078067636746837
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DCTPP1,dCTP pyrophosphatase 1,18432,70,5.16 [3.11-8.56],2.18388679696374e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DDA1,DET1- and DDB1-associated protein 1,15485,61,1.98 [1.36-2.88],0.0003824984651675
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DDR1,Epithelial discoidin domain-containing receptor 1,18597,71,7.06 [3.54-14.05],2.6749510719268444e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DDT,D-dopachrome decarboxylase,16018,64,1.81 [1.11-2.94],0.0176177856974315
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DDX39A,ATP-dependent RNA helicase DDX39A,15528,61,2.16 [1.32-3.52],0.0021238503777506
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DDX58,Antiviral innate immune response receptor RIG-I,18014,68,1.60 [1.27-2.01],7.702463690209747e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DEFB118,Beta-defensin 118,15523,61,0.36 [0.17-0.78],0.0092445771743873
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DFFA,DNA fragmentation factor subunit alpha,18653,71,1.74 [1.32-2.29],9.003834602266798e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DGKA,Diacylglycerol kinase alpha,15528,61,1.62 [1.08-2.44],0.0200717992770445
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DHPS,Deoxyhypusine synthase,15951,63,2.32 [1.83-2.93],3.270816730709641e-12
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DKK1,Dickkopf-related protein 1,18597,71,0.68 [0.48-0.97],0.03245159000348
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DKKL1,Dickkopf-like protein 1,18344,71,1.73 [1.26-2.39],0.0007950892804256
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DLL1,Delta-like protein 1,18477,72,2.81 [1.50-5.26],0.0012494882917304
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DLL4,Delta-like protein 4,15560,59,0.37 [0.19-0.72],0.0033469833052885
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DMD,Dystrophin,15560,59,1.83 [1.31-2.56],0.0004457500952726
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DNAJC9,DnaJ homolog subfamily C member 9,15956,64,1.58 [1.17-2.12],0.0027415497465765
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DNMBP,Dynamin-binding protein,18284,71,2.15 [1.68-2.75],1.649490742759635e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,18458,70,1.50 [1.01-2.24],0.0470755364635222
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DPEP2,Dipeptidase 2,18344,71,5.02 [3.08-8.17],9.090514533566212e-11
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DPY30,Protein dpy-30 homolog,18555,70,1.87 [1.48-2.36],1.738433422487811e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DSC2,Desmocollin-2,18202,69,1.84 [1.02-3.29],0.0413231998582041
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DSCAM,Down syndrome cell adhesion molecule,15987,64,3.02 [1.64-5.58],0.0004163726822078
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DTNB,Dystrobrevin beta,15913,63,1.86 [1.22-2.86],0.0042926533936231
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DTX3,Probable E3 ubiquitin-protein ligase DTX3,18344,71,7.04 [4.53-10.94],3.7380146972071385e-18
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DXO,Decapping and exoribonuclease protein,15980,64,2.29 [1.45-3.62],0.0003622917901182
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DYNLT1,Dynein light chain Tctex-type 1,15599,60,1.39 [1.07-1.81],0.0146284780650584
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EBI3_IL27,Interleukin-27,18583,70,3.49 [1.85-6.57],0.0001132469040516
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EDA2R,Tumor necrosis factor receptor superfamily member 27,18606,70,1.89 [1.14-3.15],0.0143369147483184
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EDNRB,Endothelin receptor type B,15528,61,0.44 [0.20-0.96],0.0404885009571742
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EFCAB14,EF-hand calcium-binding domain-containing protein 14,15956,64,1.79 [1.13-2.84],0.0134499926482318
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EFNA1,Ephrin-A1,18400,69,2.82 [1.53-5.19],0.0008950023432088
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EFNA4,Ephrin-A4,18250,71,9.41 [6.99-12.67],2.1472761662590146e-49
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EGFL7,Epidermal growth factor-like protein 7,18014,68,0.43 [0.24-0.77],0.0048227878286866
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EGLN1,Egl nine homolog 1,18427,71,1.90 [1.65-2.20],1.607615006600753e-18
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ELOA,Elongin-A,18344,71,2.25 [1.99-2.56],1.3027646089953896e-36
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENG,Endoglin,18663,72,6.37 [2.47-16.41],0.000124857961596
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENOX2,Ecto-NOX disulfide-thiol exchanger 2,15485,61,3.64 [2.44-5.44],2.4228764359884776e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,18663,72,4.08 [1.91-8.74],0.0002938236727922
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,18109,70,3.14 [1.28-7.72],0.0126323647512687
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENTR1,Endosome-associated-trafficking regulator 1,15560,59,1.96 [1.49-2.58],1.4228699695480098e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EPCAM,Epithelial cell adhesion molecule,18397,70,0.72 [0.56-0.92],0.0076306002347687
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EPHA2,Ephrin type-A receptor 2,17790,69,3.58 [2.16-5.94],7.718318180700733e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EPHA4,Ephrin type-A receptor 4,15659,64,4.57 [2.05-10.17],0.0001955424917545
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EPHB4,Ephrin type-B receptor 4,18663,72,2.75 [1.32-5.73],0.006852262516693
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EPHB6,Ephrin type-B receptor 6,18256,71,4.47 [2.55-7.82],1.6391629933616945e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EPO,Erythropoietin,18427,71,1.53 [1.26-1.87],2.1102343549644057e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,18578,70,5.71 [3.81-8.56],3.425108432197204e-17
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EREG,Proepiregulin,18256,71,0.61 [0.45-0.82],0.0014361930826484
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ERI1,3'-5' exoribonuclease 1,15731,62,3.55 [2.69-4.69],4.6487569052595695e-19
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EVI5,Ecotropic viral integration site 5 protein homolog,15528,61,1.31 [1.00-1.71],0.047604606015974
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EXOSC10,Exosome component 10,15485,61,1.37 [1.00-1.86],0.0473458305779113
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EZR,Ezrin,18597,71,6.73 [4.62-9.81],2.933980458920329e-23
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FAM3C,Protein FAM3C,18412,70,2.71 [1.42-5.16],0.0025010541299352
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FAS,Tumor necrosis factor receptor superfamily member 6,18603,72,1.59 [1.07-2.36],0.0215262636856697
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,16007,62,2.02 [1.48-2.75],7.721772684889052e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,15987,64,2.32 [1.05-5.16],0.0382517860762011
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCER2,Low affinity immunoglobulin epsilon Fc receptor,18432,70,3.66 [3.28-4.09],3.2690046693060525e-116
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,18014,68,1.71 [1.29-2.26],0.0001694375905451
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCRL1,Fc receptor-like protein 1,18432,70,3.36 [2.75-4.10],8.096191424632299e-33
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCRL2,Fc receptor-like protein 2,18569,71,3.66 [3.16-4.24],1.0081244649909783e-67
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCRL3,Fc receptor-like protein 3,18124,68,3.95 [3.31-4.70],1.4554728566499972e-53
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCRL5,Fc receptor-like protein 5,18432,70,4.93 [3.72-6.55],1.8861470190351447e-28
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCRLB,Fc receptor-like B,18014,68,1.51 [1.20-1.90],0.0004134006269553
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FEN1,Flap endonuclease 1,18014,68,1.58 [1.36-1.82],6.365796423060042e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGF2,Fibroblast growth factor 2,18427,71,2.02 [1.58-2.59],2.1866096938109453e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGF23,Fibroblast growth factor 23,18576,70,1.39 [1.01-1.93],0.0434950714262063
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGF5,Fibroblast growth factor 5,18124,68,1.80 [1.01-3.21],0.0454915979772456
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FGF7,Fibroblast growth factor 7,15454,61,0.48 [0.29-0.82],0.0064997511650602
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FLT3LG,Fms-related tyrosine kinase 3 ligand,18653,71,2.05 [1.14-3.68],0.0164340946421368
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FMNL1,Formin-like protein 1,18039,70,1.31 [1.05-1.62],0.015027414731488
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FOXJ3,Forkhead box protein J3,15528,61,2.00 [1.42-2.81],7.439376885762322e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FOXO1,Forkhead box protein O1,18427,71,1.68 [1.33-2.12],1.0773903550999554e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FSHB,Follitropin subunit beta,15560,59,1.61 [1.10-2.34],0.013504406720269
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FSTL3,Follistatin-related protein 3,18372,70,2.16 [1.19-3.92],0.0112313447963496
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FUS,RNA-binding protein FUS,17984,68,3.98 [3.10-5.11],3.3185369129501386e-27
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,18597,71,1.56 [1.00-2.41],0.0477883033822785
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FZD10,Frizzled-10,15599,60,0.55 [0.30-1.00],0.0497673455472626
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,18124,68,3.23 [2.39-4.37],2.3946870477208887e-14
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GALNT7,N-acetylgalactosaminyltransferase 7,18344,71,12.66 [4.99-32.09],8.840384483599198e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GAS6,Growth arrest-specific protein 6,18543,71,2.36 [1.03-5.41],0.0429120004426319
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GBP1,Guanylate-binding protein 1,15952,64,1.71 [1.26-2.32],0.0006326140347964
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GBP2,Guanylate-binding protein 2,18124,68,1.43 [1.06-1.93],0.0189731407022792
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,15282,61,2.04 [1.56-2.65],1.3326133158357013e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GDF2,Growth/differentiation factor 2,18432,70,0.49 [0.27-0.90],0.0208055167190575
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GFER,FAD-linked sulfhydryl oxidase ALR,18014,68,1.45 [1.05-1.99],0.0233299691933548
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GFRA1,GDNF family receptor alpha-1,18583,70,3.47 [1.84-6.55],0.0001208888237452
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GGT5,Glutathione hydrolase 5 proenzyme,18284,71,2.44 [1.12-5.33],0.0248106864600547
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GH2,Growth hormone variant,18014,68,0.66 [0.53-0.82],0.0002121026135205
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GIGYF2,GRB10-interacting GYF protein 2,15987,64,1.38 [1.03-1.85],0.0311287128588491
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GIPC2,PDZ domain-containing protein GIPC2,15980,64,2.72 [1.53-4.84],0.0006794603728694
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GLYR1,Putative oxidoreductase GLYR1,15951,63,1.91 [1.54-2.38],5.7287322772877366e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GM2A,Ganglioside GM2 activator,15629,61,1.92 [1.30-2.85],0.0010960153778237
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GNLY,Granulysin,18432,70,1.46 [1.00-2.12],0.0492472992661326
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GOLGA3,Golgin subfamily A member 3,15987,64,1.44 [1.09-1.91],0.0113999199630401
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GOLM2,Protein GOLM2,18597,71,1.89 [1.01-3.56],0.0475733137795817
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GP5,Platelet glycoprotein V,15659,64,0.43 [0.24-0.78],0.0052966968149853
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GPKOW,G-patch domain and KOW motifs-containing protein,18039,70,2.32 [1.74-3.09],8.764481981054419e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GPR101,Probable G-protein coupled receptor 101,15523,61,0.50 [0.26-0.96],0.0376559454649447
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GRN,Progranulin,18332,69,9.30 [6.50-13.30],2.6252932094855047e-34
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GZMA,Granzyme A,18653,71,2.69 [1.75-4.14],6.378035855734826e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GZMH,Granzyme H,18109,70,1.37 [1.16-1.63],0.0002601536163788
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HAVCR2,Hepatitis A virus cellular receptor 2,18432,70,2.79 [1.71-4.55],3.7760863750540416e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HBEGF,Proheparin-binding EGF-like growth factor,18557,70,0.60 [0.45-0.80],0.0004793814604255
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HCLS1,Hematopoietic lineage cell-specific protein,18653,71,1.58 [1.08-2.33],0.0194808516544383
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HDGFL2,Hepatoma-derived growth factor-related protein 2,15980,64,2.42 [1.97-2.97],3.682138930066411e-17
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HHEX,Hematopoietically-expressed homeobox protein HHEX,15980,64,1.57 [1.16-2.11],0.0032298894244475
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HIP1R,Huntingtin-interacting protein 1-related protein,15945,64,1.49 [1.10-2.02],0.0098782392407818
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",18364,70,2.13 [1.28-3.55],0.0037128244485831
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",18427,71,3.09 [1.81-5.27],3.597081282496369e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HMOX2,Heme oxygenase 2,18039,70,2.08 [1.66-2.61],1.8277396064729358e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HNRNPK,Heterogeneous nuclear ribonucleoprotein K,18043,69,1.46 [1.13-1.88],0.0034856870923205
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,15987,64,2.02 [1.64-2.49],2.6983924015486947e-11
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,18606,70,1.66 [1.10-2.51],0.0155364188917697
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HYOU1,Hypoxia up-regulated protein 1,18663,72,4.39 [1.86-10.39],0.0007554806073558
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ICAM1,Intercellular adhesion molecule 1,18374,68,4.04 [2.20-7.41],6.631651041496177e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ICAM2,Intercellular adhesion molecule 2,18663,72,1.95 [1.02-3.73],0.0442995761397677
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ICAM3,Intercellular adhesion molecule 3,18663,72,22.24 [15.61-31.67],3.0526670423003124e-66
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ICOSLG,ICOS ligand,18344,71,10.46 [3.57-30.64],1.836834165648631e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,15594,64,3.98 [2.64-5.99],3.971678750640568e-11
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IFNAR1,Interferon alpha/beta receptor 1,15956,64,2.50 [1.29-4.82],0.0063957169656352
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IFNGR1,Interferon gamma receptor 1,18492,70,3.18 [1.85-5.48],3.080085093674548e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IFNLR1,Interferon lambda receptor 1,18427,71,2.78 [2.19-3.54],8.761341755561712e-17
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IFNW1,Interferon omega-1,15485,61,0.33 [0.12-0.89],0.0283084334708339
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGF2R,Cation-independent mannose-6-phosphate receptor,18432,70,6.47 [2.97-14.13],2.7570944269724338e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGFBP4,Insulin-like growth factor-binding protein 4,18209,70,1.59 [1.05-2.43],0.03021648634472
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGFBP7,Insulin-like growth factor-binding protein 7,18663,72,1.87 [1.18-2.98],0.0078496836991294
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGSF3,Immunoglobulin superfamily member 3,18344,71,4.82 [4.05-5.75],1.5415928470991078e-69
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGSF8,Immunoglobulin superfamily member 8,18432,70,1.81 [1.03-3.19],0.0390671488619551
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IKBKG,NF-kappa-B essential modulator,18427,71,1.33 [1.06-1.68],0.0154736325328251
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL10,Interleukin-10,18124,68,1.55 [1.31-1.83],3.2359405503679865e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL10RB,Interleukin-10 receptor subunit beta,18492,70,2.56 [1.72-3.81],3.954691203249269e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL12A_IL12B,Interleukin-12,18344,71,1.79 [1.41-2.28],2.400357376558175e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL12B,Interleukin-12 subunit beta,18653,71,2.28 [1.58-3.28],1.0782338345492104e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL12RB1,Interleukin-12 receptor subunit beta-1,18124,68,3.65 [2.53-5.28],5.95924785889668e-12
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL12RB2,Interleukin-12 receptor subunit beta-2,15528,61,1.93 [1.28-2.90],0.0016084221683165
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL15RA,Interleukin-15 receptor subunit alpha,18124,68,4.52 [2.67-7.67],2.031504687668372e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL16,Pro-interleukin-16,18653,71,2.63 [2.06-3.36],1.0583102142715344e-14
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL17C,Interleukin-17C,18124,68,1.32 [1.03-1.69],0.0312534948589866
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL18BP,Interleukin-18-binding protein,18520,69,5.65 [3.44-9.28],8.227318751013179e-12
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL18RAP,Interleukin-18 receptor accessory protein,18171,71,0.83 [0.71-0.96],0.0133900695858079
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL1R1,Interleukin-1 receptor type 1,18400,69,2.90 [1.33-6.36],0.0077137513696019
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL1RAP,Interleukin-1 receptor accessory protein,18432,70,1.64 [1.06-2.53],0.0273598793269269
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL2RA,Interleukin-2 receptor subunit alpha,18317,71,4.51 [3.51-5.79],6.241724427176763e-32
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL2RG,Cytokine receptor common subunit gamma,15951,63,2.27 [1.68-3.08],1.2246491806513329e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL4R,Interleukin-4 receptor subunit alpha,18427,71,4.82 [3.52-6.61],1.3463182379242758e-22
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL5RA,Interleukin-5 receptor subunit alpha,18427,71,0.37 [0.25-0.55],6.805316356042561e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL6R,Interleukin-6 receptor subunit alpha,18349,68,2.18 [1.18-4.05],0.0133619178487215
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL7,Interleukin-7,18427,71,0.52 [0.37-0.73],0.0002141381641812
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,18007,69,1.77 [1.46-2.14],6.464963829193295e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IMMT,MICOS complex subunit MIC60,15951,63,1.53 [1.01-2.31],0.0436363732549004
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ING1,Inhibitor of growth protein 1,18011,70,2.18 [1.84-2.58],1.3527241768798422e-19
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",INHBB,Inhibin beta B chain,15659,64,1.76 [1.15-2.69],0.0088440195631009
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",15560,59,3.44 [2.48-4.78],1.4599767769083782e-13
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",INSR,Insulin receptor,15528,61,5.93 [1.62-21.66],0.0070879824779297
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",18109,70,1.64 [1.38-1.94],1.7405041783892288e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,17763,68,0.45 [0.25-0.78],0.0048783498128257
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITGA11,Integrin alpha-11,18427,71,0.51 [0.28-0.95],0.0332474660344543
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITGA6,Integrin alpha-6,18427,71,0.57 [0.36-0.90],0.0164354684114382
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITGAL,Integrin alpha-L,15528,61,3.51 [1.97-6.26],2.0175531072351337e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITGAX,Integrin alpha-X,15731,62,0.61 [0.41-0.90],0.011790180716437
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,18520,69,2.16 [1.24-3.77],0.0064808485908652
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",JAM2,Junctional adhesion molecule B,18597,71,2.17 [1.06-4.42],0.0339130892025512
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",JUN,Transcription factor AP-1,18124,68,1.54 [1.20-1.99],0.0008270836287661
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,18344,71,2.29 [1.39-3.77],0.0011230720576311
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KCNC4,Potassium voltage-gated channel subfamily C member 4,15523,61,0.37 [0.18-0.76],0.0069452165275539
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KCNH2,Potassium voltage-gated channel subfamily H member 2,15599,60,0.56 [0.33-0.96],0.0347069077128207
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KCTD5,BTB/POZ domain-containing protein KCTD5,15663,61,0.37 [0.18-0.76],0.0071473339055472
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KEL,Kell blood group glycoprotein,18039,70,1.99 [1.12-3.54],0.0184000591544495
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KIF1C,Kinesin-like protein KIF1C,15485,61,1.68 [1.05-2.68],0.0294565935666198
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KIF22,Kinesin-like protein KIF22,15485,61,1.48 [1.18-1.85],0.000635981046963
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,15951,63,1.33 [1.02-1.73],0.0356665614557362
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLF4,Krueppel-like factor 4,15523,61,1.81 [1.28-2.57],0.0007958505250795
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLK10,Kallikrein-10,18424,72,0.43 [0.26-0.72],0.0014277105388697
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLK7,Kallikrein-7,15277,62,0.31 [0.16-0.60],0.000577137035528
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLRB1,Killer cell lectin-like receptor subfamily B member 1,18653,71,1.95 [1.16-3.26],0.0112886825600768
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KLRK1,NKG2-D type II integral membrane protein,15980,64,1.69 [1.15-2.48],0.0072445802020724
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KYAT1,Kynurenine--oxoglutarate transaminase 1,18401,70,1.70 [1.23-2.36],0.0013546050037081
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",L1CAM,Neural cell adhesion molecule L1,18477,72,5.48 [2.91-10.34],1.4623288260215946e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LAG3,Lymphocyte activation gene 3 protein,18344,71,2.63 [2.05-3.39],5.81991677414281e-14
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,18402,70,2.11 [1.41-3.15],0.0002976456548511
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LAYN,Layilin,18256,71,2.34 [1.42-3.87],0.0009032194187339
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LEFTY2,Left-right determination factor 2,18583,70,0.62 [0.41-0.92],0.0192181759401827
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LEP,Leptin,18432,70,0.72 [0.53-0.97],0.0306972580809273
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LGALS9,Galectin-9,18413,70,3.52 [1.97-6.29],2.2073741698428705e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,18429,70,1.44 [1.04-1.99],0.0287051479444773
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,18663,72,10.90 [5.82-20.41],8.243305374595985e-14
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,18572,71,3.37 [1.79-6.33],0.0001663515068576
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,18124,68,2.96 [1.95-4.50],3.371726646997685e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LMNB1,Lamin-B1,15929,64,1.59 [1.26-2.01],7.99976562813524e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LMNB2,Lamin-B2,15980,64,3.20 [1.86-5.49],2.5495675234455862e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,15485,61,1.82 [1.40-2.38],1.0689450858438412e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRG1,Leucine-rich alpha-2-glycoprotein,16032,63,4.98 [2.24-11.04],7.912243687389236e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRP11,Low-density lipoprotein receptor-related protein 11,18432,70,1.74 [1.00-3.02],0.0490320435434184
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRRC25,Leucine-rich repeat-containing protein 25,18344,71,1.78 [1.25-2.54],0.0012907131047152
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRRC37A2,Leucine-rich repeat-containing protein 37A2,15956,64,6.60 [3.99-10.92],2.078891029831017e-13
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,15951,63,1.69 [1.10-2.58],0.0159395768126277
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRRN1,Leucine-rich repeat neuronal protein 1,18124,68,1.84 [1.06-3.18],0.0298432721200628
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LSM1,U6 snRNA-associated Sm-like protein LSm1,18014,68,0.50 [0.30-0.83],0.007334983357496
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LSP1,Lymphocyte-specific protein 1,18427,71,6.84 [4.93-9.49],1.4470091120168123e-30
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LTB,Lymphotoxin-beta,15951,63,1.82 [1.29-2.57],0.000633337897688
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LTBP2,Latent-transforming growth factor beta-binding protein 2,18663,72,1.95 [1.04-3.66],0.0380286201938807
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LTBP3,Latent-transforming growth factor beta-binding protein 3,18014,68,1.63 [1.26-2.10],0.0002048673164746
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LTBR,Tumor necrosis factor receptor superfamily member 3,18310,70,2.36 [1.26-4.45],0.0076303078221206
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LUZP2,Leucine zipper protein 2,15951,63,1.62 [1.08-2.43],0.0189200692014137
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LY75,Lymphocyte antigen 75,18427,71,5.49 [3.04-9.90],1.493588661211916e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LY9,T-lymphocyte surface antigen Ly-9,18205,71,24.58 [17.25-35.01],2.1864261146341183e-70
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LY96,Lymphocyte antigen 96,18284,71,0.31 [0.17-0.57],0.0001747935085026
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LYAR,Cell growth-regulating nucleolar protein,18014,68,1.73 [1.51-1.99],1.0704622418660308e-14
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LYPD1,Ly6/PLAUR domain-containing protein 1,18039,70,0.46 [0.25-0.85],0.0128937487219758
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LYPD3,Ly6/PLAUR domain-containing protein 3,18337,72,2.52 [1.54-4.13],0.0002343332846047
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LYPD8,Ly6/PLAUR domain-containing protein 8,18014,68,1.42 [1.10-1.83],0.0070163924761184
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,18227,71,1.90 [1.60-2.27],8.049228408444399e-13
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAGED1,Melanoma-associated antigen D1,18014,68,1.83 [1.32-2.54],0.0003133266430733
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",15560,59,11.79 [4.64-29.98],2.203892270329938e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAP2,Microtubule-associated protein 2,15980,64,2.27 [1.76-2.94],2.7409940909477166e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAPK13,Mitogen-activated protein kinase 13,15454,61,1.98 [1.49-2.62],2.080166939170536e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MARCO,Macrophage receptor MARCO,18432,70,2.81 [1.23-6.42],0.0139046889870818
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MERTK,Tyrosine-protein kinase Mer,18653,71,2.69 [1.19-6.08],0.0172168307039512
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MILR1,Allergin-1,18124,68,1.73 [1.17-2.55],0.0057531425614143
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MNAT1,CDK-activating kinase assembly factor MAT1,15731,62,1.59 [1.12-2.25],0.0090366850920074
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MORC3,MORC family CW-type zinc finger protein 3,15980,64,3.29 [2.26-4.78],4.2119389619991957e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MORF4L1,Mortality factor 4-like protein 1,15731,62,1.53 [1.04-2.25],0.0325464927665393
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MORF4L2,Mortality factor 4-like protein 2,15454,61,2.00 [1.30-3.07],0.0015096638429153
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MSLN,Mesothelin,18314,71,1.45 [1.04-2.02],0.0295036801990898
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MTDH,Protein LYRIC,15528,61,1.39 [1.08-1.79],0.0098304013341181
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MYCBP2,E3 ubiquitin-protein ligase MYCBP2,15987,64,1.81 [1.45-2.25],1.1417866879344209e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MYH7B,Myosin-7B,15454,61,0.35 [0.16-0.76],0.0078393245359686
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MZB1,Marginal zone B- and B1-cell-specific protein,18453,70,0.58 [0.38-0.89],0.0120426504942415
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NACC1,Nucleus accumbens-associated protein 1,15951,63,1.86 [1.41-2.45],1.1136008490326031e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NAGK,N-acetyl-D-glucosamine kinase,15532,59,2.23 [1.54-3.25],2.4216156878499303e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,15659,64,5.70 [2.28-14.23],0.0001918989187776
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NAP1L4,Nucleosome assembly protein 1-like 4,15918,64,2.08 [1.11-3.89],0.0217592774409571
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NBN,Nibrin,18124,68,2.11 [1.85-2.42],1.065312252483144e-27
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NECTIN2,Nectin-2,18412,70,1.95 [1.04-3.66],0.0378793056745384
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NELL1,Protein kinase C-binding protein NELL1,18477,72,0.54 [0.33-0.88],0.0127292039451033
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",18427,71,1.42 [1.16-1.75],0.0007078855639139
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NFKB1,Nuclear factor NF-kappa-B p105 subunit,15485,61,1.94 [1.42-2.65],3.577243191586477e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NFKBIE,NF-kappa-B inhibitor epsilon,18014,68,3.78 [2.89-4.94],1.625303661990104e-22
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NFX1,Transcriptional repressor NF-X1,15485,61,1.43 [1.05-1.95],0.0244762664105986
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NFYA,Nuclear transcription factor Y subunit alpha,15485,61,2.48 [1.98-3.12],4.2639313183913166e-15
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NGRN,Neugrin,15980,64,2.47 [1.29-4.73],0.0061904741860127
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NHLRC3,NHL repeat-containing protein 3,15291,61,2.99 [1.34-6.67],0.0073748438553658
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NLGN2,Neuroligin-2,15523,61,0.47 [0.22-1.00],0.049219193455625
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,18284,71,1.83 [1.63-2.06],9.759613312485294e-24
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NOS3,"Nitric oxide synthase, endothelial",18039,70,1.61 [1.23-2.10],0.0005350572433068
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NOTCH1,Neurogenic locus notch homolog protein 1,18663,72,4.13 [2.09-8.17],4.470322849068502e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NPC2,NPC intracellular cholesterol transporter 2,15754,61,2.73 [1.59-4.71],0.0002927328425118
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NPDC1,Neural proliferation differentiation and control protein 1,18432,70,1.94 [1.12-3.35],0.017684740909046
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NPHS1,Nephrin,15528,61,0.45 [0.21-0.97],0.0426307112194065
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NPTN,Neuroplastin,18014,68,0.61 [0.40-0.93],0.0223404452339237
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NPTX2,Neuronal pentraxin-2,16018,64,0.39 [0.20-0.76],0.0060867533525746
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NRCAM,Neuronal cell adhesion molecule,18432,70,4.38 [2.29-8.37],8.050615330116158e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NRP2,Neuropilin-2,18432,70,2.20 [1.15-4.21],0.0171799780107459
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NT5C1A,Cytosolic 5'-nucleotidase 1A,15980,64,1.99 [1.28-3.10],0.0023309873576794
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NTproBNP,N-terminal prohormone of brain natriuretic peptide,18432,70,1.19 [1.00-1.41],0.0490714866476678
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OCLN,Occludin,15987,64,1.99 [1.32-3.00],0.0010912372946207
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OGA,Protein O-GlcNAcase,15956,64,1.65 [1.19-2.29],0.0027498336065817
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OGFR,Opioid growth factor receptor,18344,71,4.10 [2.50-6.72],2.42909966603854e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OPLAH,5-oxoprolinase,15560,59,1.44 [1.03-2.03],0.0354274191245873
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ORM1,Alpha-1-acid glycoprotein 1,15971,63,3.66 [1.27-10.56],0.0162292001871702
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OTOA,Otoancorin,15523,61,0.44 [0.22-0.88],0.0204838823604798
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PAIP2B,Polyadenylate-binding protein-interacting protein 2B,15427,61,1.62 [1.13-2.33],0.0085652581254583
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PAMR1,Inactive serine protease PAMR1,18432,70,0.34 [0.16-0.75],0.0070781394453095
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PARP1,Poly [ADP-ribose] polymerase 1,18427,71,1.96 [1.76-2.19],1.189386140401973e-33
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,15956,64,2.13 [1.27-3.56],0.0041959217331943
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PCDH9,Protocadherin-9,15956,64,9.46 [5.42-16.49],2.345317274272668e-15
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PCSK7,Proprotein convertase subtilisin/kexin type 7,15951,63,1.55 [1.13-2.11],0.0059749312994202
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDCD1,Programmed cell death protein 1,18574,70,6.40 [4.90-8.37],5.945096613405115e-42
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDCL2,Phosducin-like protein 2,15454,61,1.49 [1.10-2.02],0.0105785422925989
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDGFA,Platelet-derived growth factor subunit A,18663,72,0.70 [0.53-0.93],0.0129012513927486
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDGFB,Platelet-derived growth factor subunit B,18492,70,0.77 [0.60-0.97],0.0282729840085122
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PEBP1,Phosphatidylethanolamine-binding protein 1,18432,70,1.51 [1.07-2.13],0.0183170088274523
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",18318,71,1.56 [1.22-1.99],0.0003580754710619
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PGLYRP4,Peptidoglycan recognition protein 4,15485,61,0.36 [0.19-0.69],0.002024447576907
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",15987,64,1.50 [1.14-1.97],0.0035578269628685
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,18427,71,2.94 [2.35-3.68],6.160911165748098e-21
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,18432,70,3.82 [2.26-6.43],4.919438372508837e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,15659,64,0.72 [0.53-1.00],0.0486958728655936
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PKLR,Pyruvate kinase PKLR,18437,70,1.40 [1.04-1.89],0.0280970700746518
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLA2G15,Phospholipase A2 group XV,18477,72,2.60 [1.29-5.24],0.0076351742817743
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLEKHO1,Pleckstrin homology domain-containing family O member 1,15980,64,1.51 [1.09-2.09],0.0120355728764736
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLXNB2,Plexin-B2,18580,72,2.40 [1.10-5.24],0.0281142355295832
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PLXNB3,Plexin-B3,18370,69,0.62 [0.40-0.97],0.0358405894132841
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PMS1,PMS1 protein homolog 1,15599,60,2.06 [1.66-2.56],6.621090968239888e-11
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PNMA2,Paraneoplastic antigen Ma2,15523,61,2.10 [1.61-2.74],4.44977138683501e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",18124,68,0.78 [0.61-0.99],0.0430172058426421
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",POF1B,Protein POF1B,15528,61,1.85 [1.35-2.53],0.0001243149322708
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",18344,71,2.83 [2.29-3.49],3.189996113210883e-22
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",POSTN,Periostin,16018,64,0.40 [0.21-0.77],0.0056492471653326
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PPBP,Platelet basic protein,15907,62,0.70 [0.53-0.93],0.0132814712453593
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PQBP1,Polyglutamine-binding protein 1,18014,68,1.93 [1.67-2.23],1.5968983793860793e-18
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRG3,Proteoglycan 3,16018,64,0.51 [0.32-0.81],0.0043561457939226
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,15945,63,1.36 [1.01-1.85],0.0457707183024573
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,18014,68,2.21 [1.71-2.86],1.4998005397628623e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PROK1,Prokineticin-1,18427,71,0.52 [0.33-0.81],0.0039030657369553
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRRT3,Proline-rich transmembrane protein 3,15560,59,3.63 [2.15-6.13],1.4672810485890638e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRSS8,Prostasin,18349,69,1.74 [1.06-2.86],0.0273574056649788
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSIP1,PC4 and SFRS1-interacting protein,18427,71,1.99 [1.73-2.29],1.7211620978069631e-22
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSMG3,Proteasome assembly chaperone 3,18427,71,1.58 [1.07-2.32],0.0218634815125598
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSMG4,Proteasome assembly chaperone 4,15528,61,1.50 [1.06-2.12],0.0214866565906264
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSPN,Persephin,18427,71,0.70 [0.56-0.89],0.0027136461636685
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTGDS,Prostaglandin-H2 D-isomerase,18323,68,2.93 [1.80-4.78],1.554216787999686e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTK7,Inactive tyrosine-protein kinase 7,18039,70,0.55 [0.34-0.91],0.0201240865251322
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTPN1,Tyrosine-protein phosphatase non-receptor type 1,18284,71,1.72 [1.37-2.16],2.8858101323642126e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTPRC,Receptor-type tyrosine-protein phosphatase C,16018,64,14.63 [9.58-22.33],1.8186381778330472e-35
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTPRH,Receptor-type tyrosine-protein phosphatase H,15956,64,1.69 [1.09-2.62],0.0187489824027457
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTPRS,Receptor-type tyrosine-protein phosphatase S,18663,72,3.52 [1.60-7.72],0.0016889536864265
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTS,6-pyruvoyl tetrahydrobiopterin synthase,17945,69,1.74 [1.27-2.38],0.0005733631673807
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PTX3,Pentraxin-related protein PTX3,18427,71,1.88 [1.12-3.13],0.0160255389184117
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",QSOX1,Sulfhydryl oxidase 1,15711,61,1.51 [1.08-2.09],0.0147146355149318
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RAB37,Ras-related protein Rab-37,18124,68,0.59 [0.41-0.85],0.0041857536618955
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,15523,61,0.54 [0.29-0.99],0.0463210913439884
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RABEP1,Rab GTPase-binding effector protein 1,15659,64,1.39 [1.03-1.88],0.0328107334651324
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RABGAP1L,Rab GTPase-activating protein 1-like,18124,68,1.71 [1.26-2.33],0.0006746367187684
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RAC3,Ras-related C3 botulinum toxin substrate 3,15599,60,0.46 [0.24-0.87],0.017547361526928
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RALY,RNA-binding protein Raly,15951,63,1.98 [1.56-2.52],1.5554687539350015e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RASSF2,Ras association domain-containing protein 2,18014,68,1.62 [1.38-1.90],6.1181280973445725e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RBKS,Ribokinase,18014,71,1.71 [1.15-2.55],0.0081761408097507
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RBM19,Probable RNA-binding protein 19,15485,61,1.99 [1.56-2.53],2.219290311729396e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RBP5,Retinol-binding protein 5,18344,71,1.66 [1.17-2.35],0.004437636690279
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RCC1,Regulator of chromosome condensation,15951,63,1.41 [1.01-1.97],0.0432024229967814
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",REG1A,Lithostathine-1-alpha,18344,68,1.50 [1.03-2.18],0.0352515249084092
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",REG1B,Lithostathine-1-beta,18663,72,1.42 [1.04-1.96],0.0298180914379925
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RELB,Transcription factor RelB,15528,61,0.46 [0.23-0.93],0.0303589513586702
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RELT,Tumor necrosis factor receptor superfamily member 19L,18432,70,3.32 [1.88-5.88],3.587102588445565e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",REN,Renin,18432,70,0.75 [0.56-0.99],0.0437705837478962
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",REXO2,"Oligoribonuclease, mitochondrial",15485,61,0.41 [0.19-0.89],0.0241059089310235
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RFC4,Replication factor C subunit 4,15951,63,2.77 [1.31-5.85],0.00782211574345
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RGMB,RGM domain family member B,18597,71,2.50 [1.25-5.02],0.009897521425192
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RIPK4,Receptor-interacting serine/threonine-protein kinase 4,15485,61,0.50 [0.28-0.89],0.0181579725826957
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RNASE6,Ribonuclease K6,15919,61,1.97 [1.36-2.84],0.0003123820102385
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RNASET2,Ribonuclease T2,18577,71,3.03 [1.56-5.88],0.0010259621938665
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RNF149,E3 ubiquitin-protein ligase RNF149,15560,59,3.90 [2.10-7.24],1.5574567627101162e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RNF168,E3 ubiquitin-protein ligase RNF168,15528,61,1.80 [1.23-2.62],0.0024333645671501
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ROBO1,Roundabout homolog 1,18432,70,4.62 [2.20-9.69],5.131669063739409e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,18432,70,7.02 [3.86-12.76],1.7008941551624095e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RPL14,60S ribosomal protein L14,15560,59,5.53 [3.52-8.69],1.2511108843584897e-13
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RRM2,Ribonucleoside-diphosphate reductase subunit M2,18014,68,1.64 [1.25-2.16],0.0003898427206562
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,18014,68,1.53 [1.12-2.07],0.0068264638659064
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RTN4R,Reticulon-4 receptor,18606,70,2.04 [1.22-3.43],0.0069381643030491
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",S100A13,Protein S100-A13,15528,61,1.81 [1.03-3.18],0.0383944973656871
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",S100A3,Protein S100-A3,15951,63,1.42 [1.04-1.94],0.027929507400728
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SAFB2,Scaffold attachment factor B2,15987,64,2.16 [1.53-3.06],1.2366868743588692e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SART1,U4/U6.U5 tri-snRNP-associated protein 1,15485,61,2.24 [1.90-2.64],7.146666637244323e-22
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCAMP3,Secretory carrier-associated membrane protein 3,18344,71,1.69 [1.34-2.13],7.142255444942486e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCARB2,Lysosome membrane protein 2,17932,69,2.28 [1.31-3.98],0.0037059448042173
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCARF2,Scavenger receptor class F member 2,18597,71,2.28 [1.14-4.53],0.0193058271539028
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCRIB,Protein scribble homolog,15560,59,1.32 [1.07-1.63],0.0091397604220822
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SCRN1,Secernin-1,18427,71,1.60 [1.17-2.19],0.0035050161822583
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SDC4,Syndecan-4,18432,70,0.50 [0.37-0.66],1.83694084715836e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SDCCAG8,Serologically defined colon cancer antigen 8,15951,63,1.29 [1.04-1.60],0.0188067836862561
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SDHB,Succinate dehydrogenase,15956,64,1.38 [1.03-1.85],0.03227264990839
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SDK2,Protein sidekick-2,15659,64,4.08 [3.35-4.95],2.6312487769848905e-45
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SELL,L-selectin,16032,63,10.30 [6.76-15.68],1.5942536569191218e-27
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SELPLG,P-selectin glycoprotein ligand 1,18427,71,2.75 [1.52-4.96],0.0007828103908915
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEMA3G,Semaphorin-3G,15659,64,2.06 [1.35-3.14],0.0008156128432927
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEMA4C,Semaphorin-4C,18344,71,1.83 [1.19-2.82],0.0059383836215279
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEMA4D,Semaphorin-4D,18597,71,2.15 [1.06-4.34],0.0332136102830101
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEMA7A,Semaphorin-7A,18603,72,5.82 [4.27-7.93],6.696356949803479e-29
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEPTIN3,Neuronal-specific septin-3,15987,64,0.69 [0.49-0.97],0.0324694139894138
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEPTIN8,Septin-8,15948,64,2.36 [1.44-3.87],0.0006837757305567
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEPTIN9,Septin-9,18344,71,3.06 [2.10-4.44],5.039367769638272e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINA6,Corticosteroid-binding globulin,16032,63,5.35 [1.29-22.22],0.0210910571461549
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINA9,Serpin A9,18266,71,0.63 [0.47-0.84],0.0018498032939473
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINB8,Serpin B8,18653,71,1.58 [1.29-1.94],9.651878880882162e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINE1,Plasminogen activator inhibitor 1,18663,72,0.71 [0.52-0.95],0.0237507552249966
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SERPINE2,Glia-derived nexin,16007,62,0.63 [0.43-0.94],0.0243268244218002
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SETMAR,Histone-lysine N-methyltransferase SETMAR,18216,70,3.37 [2.14-5.30],1.518353603813772e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SFRP1,Secreted frizzled-related protein 1,18217,71,0.43 [0.25-0.74],0.0023998160596898
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SH3BP1,SH3 domain-binding protein 1,15956,64,1.44 [1.02-2.04],0.0399228235214849
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SH3GLB2,Endophilin-B2,15980,64,1.43 [1.01-2.02],0.0440736938350404
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SHISA5,Protein shisa-5,16018,64,2.61 [1.42-4.79],0.0019916948326262
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIGLEC1,Sialoadhesin,18492,70,2.79 [1.85-4.20],8.840226551507495e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIGLEC5,Sialic acid-binding Ig-like lectin 5,18432,70,1.57 [1.21-2.04],0.0006933387660268
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIGLEC6,Sialic acid-binding Ig-like lectin 6,18606,70,8.64 [6.52-11.46],7.829402916901134e-51
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIGLEC8,Sialic acid-binding Ig-like lectin 8,15560,59,3.05 [1.87-5.00],9.036210745820729e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,18481,71,1.57 [1.04-2.39],0.0332329329772015
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIRT1,NAD-dependent protein deacetylase sirtuin-1,15528,61,1.28 [1.05-1.56],0.0131048975787113
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",18039,70,0.61 [0.37-1.00],0.0497674612323472
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIT1,Signaling threshold-regulating transmembrane adapter 1,18124,68,2.75 [1.93-3.92],2.4264673548611578e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLAMF6,SLAM family member 6,18014,68,4.66 [3.72-5.84],8.783286014247877e-41
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLAMF7,SLAM family member 7,18427,71,0.69 [0.48-1.00],0.047158927475379
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLAMF8,SLAM family member 8,18014,68,2.64 [1.84-3.78],1.2388730500732157e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLITRK2,SLIT and NTRK-like protein 2,18606,70,2.39 [1.50-3.83],0.0002618805360162
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SMAD5,Mothers against decapentaplegic homolog 5,18344,71,0.32 [0.13-0.75],0.0094768600596841
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SMNDC1,Survival of motor neuron-related-splicing factor 30,15956,64,2.21 [1.94-2.52],1.4579526044783269e-33
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SNAPIN,SNARE-associated protein Snapin,15987,64,1.51 [1.04-2.21],0.0316311358663056
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SNRPB2,U2 small nuclear ribonucleoprotein B'',15980,64,0.40 [0.18-0.93],0.0336677342149547
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SNU13,NHP2-like protein 1,15485,61,1.83 [1.51-2.21],3.664248008404077e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SNX18,Sorting nexin-18,15956,64,1.69 [1.15-2.48],0.0077211740675513
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SNX2,Sorting nexin-2,15951,63,1.29 [1.03-1.62],0.0298715529279665
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SNX5,Sorting nexin-5,15560,59,2.12 [1.07-4.20],0.0306920641457154
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SORCS2,VPS10 domain-containing receptor SorCS2,18014,68,2.14 [1.19-3.83],0.010713300064609
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPARCL1,SPARC-like protein 1,18456,69,1.76 [1.06-2.91],0.0279415921513509
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPESP1,Sperm equatorial segment protein 1,16007,62,2.06 [1.09-3.88],0.0259413594426946
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPINT1,Kunitz-type protease inhibitor 1,18365,69,5.19 [3.12-8.62],2.161025473149068e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPINT3,Kunitz-type protease inhibitor 3,15956,64,0.85 [0.74-0.97],0.0150063557745581
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPRING1,SREBP regulating gene protein,15454,61,1.55 [1.22-1.96],0.0003467709985358
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPTBN2,"Spectrin beta chain, non-erythrocytic 2",15523,61,2.54 [1.78-3.63],2.6317856482928055e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SRP14,Signal recognition particle 14 kDa protein,18344,71,2.77 [2.28-3.36],5.111241523415993e-25
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SRPK2,SRSF protein kinase 2,18427,71,1.49 [1.21-1.83],0.0001954942910265
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",18344,71,1.76 [1.27-2.46],0.0007496678493549
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STAT2,Signal transducer and activator of transcription 2,15528,61,1.51 [1.12-2.03],0.0063598529978277
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STC1,Stanniocalcin-1,18597,71,9.21 [7.32-11.59],8.300976688652306e-80
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STC2,Stanniocalcin-2,18410,70,4.93 [2.05-11.83],0.0003573422392381
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STX7,Syntaxin-7,15528,61,2.62 [1.62-4.24],8.829709837864227e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SUGP1,SURP and G-patch domain-containing protein 1,15956,64,2.10 [1.34-3.31],0.0012977714881458
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SWAP70,Switch-associated protein 70,15956,64,2.90 [2.34-3.60],3.258622798573132e-22
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TAP1,Antigen peptide transporter 1,15731,62,0.46 [0.24-0.85],0.0136435675374387
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TAX1BP1,Tax1-binding protein 1,15980,64,2.53 [1.94-3.28],4.464741416514124e-12
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TCL1A,T-cell leukemia/lymphoma protein 1A,18261,71,2.92 [2.55-3.34],6.384388373840558e-54
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TCN2,Transcobalamin-2,18632,71,1.87 [1.03-3.40],0.0406482647425162
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TCOF1,Treacle protein,16007,62,2.87 [2.24-3.69],1.7573046103395416e-16
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TDP1,Tyrosyl-DNA phosphodiesterase 1,15951,63,1.77 [1.49-2.10],6.249156002713087e-11
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TDRKH,Tudor and KH domain-containing protein,18039,70,1.33 [1.06-1.66],0.0145780387858471
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TFRC,Transferrin receptor protein 1,18521,69,2.52 [1.59-3.99],8.02634188420102e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TG,Thyroglobulin,15951,63,0.74 [0.57-0.97],0.0273544113934754
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TGFA,Protransforming growth factor alpha,18427,71,1.63 [1.08-2.45],0.0187847611563786
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TGFBR2,TGF-beta receptor type-2,18477,72,1.87 [1.08-3.22],0.0250428907683236
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TGM2,Protein-glutamine gamma-glutamyltransferase 2,18399,69,1.37 [1.03-1.81],0.0289143249613475
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TGOLN2,Trans-Golgi network integral membrane protein 2,16029,64,3.54 [1.64-7.66],0.0013264773819477
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",THAP12,52 kDa repressor of the inhibitor of the protein kinase,15427,61,1.31 [1.06-1.61],0.0113621940933561
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",THBD,Thrombomodulin,18432,70,2.66 [1.77-4.00],2.440421341551386e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",THOP1,Thimet oligopeptidase,18349,70,2.12 [1.21-3.73],0.0090077132361621
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",THY1,Thy-1 membrane glycoprotein,18597,71,2.32 [1.16-4.64],0.0176927230480869
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TIE1,Tyrosine-protein kinase receptor Tie-1,18663,72,1.97 [1.04-3.76],0.0382570553628528
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TIGAR,"Fructose-2,6-bisphosphatase TIGAR",18011,70,1.98 [1.44-2.71],2.205337943422221e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,18520,69,3.06 [2.02-4.64],1.3619091317792166e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TINAGL1,Tubulointerstitial nephritis antigen-like,18383,70,2.70 [1.06-6.89],0.0377784480882484
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TK1,"Thymidine kinase, cytosolic",15731,62,1.71 [1.22-2.39],0.0020269969190385
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TLR1,Toll-like receptor 1,15528,61,2.92 [1.42-6.00],0.0036219190744254
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TMPRSS11B,Transmembrane protease serine 11B,15523,61,0.54 [0.33-0.87],0.012255738175713
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TMPRSS15,Enteropeptidase,18344,71,0.76 [0.60-0.97],0.0269413584125878
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TMSB10,Thymosin beta-10,18432,70,1.63 [1.25-2.12],0.0003489291520231
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNC,Tenascin,18520,69,1.73 [1.14-2.64],0.0104841984407549
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNF,Tumor necrosis factor,18084,70,2.10 [1.65-2.67],1.4232596052426291e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,18284,71,0.44 [0.22-0.90],0.0249126215037212
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,18284,71,1.55 [1.31-1.84],3.466946482580712e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,18432,70,4.35 [3.60-5.26],3.862531204197715e-52
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,18124,68,4.06 [3.44-4.79],2.040906845988937e-61
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,18432,70,2.60 [1.45-4.64],0.0013136660104853
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF17,Tumor necrosis factor receptor superfamily member 17,15659,64,4.03 [2.41-6.74],1.0298309037809184e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF19,Tumor necrosis factor receptor superfamily member 19,18606,70,1.96 [1.11-3.46],0.0211104741092992
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,18432,70,2.64 [1.49-4.68],0.0008592232029657
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,18432,70,2.00 [1.59-2.51],2.887931556959417e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF21,Tumor necrosis factor receptor superfamily member 21,18597,71,2.57 [1.28-5.16],0.0078172788663354
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,18620,71,6.02 [4.22-8.58],3.3552362113020624e-23
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF8,Tumor necrosis factor receptor superfamily member 8,18597,71,2.84 [2.06-3.90],1.4203561009675422e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,18284,71,4.68 [4.09-5.36],1.282540922118068e-110
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFSF13,Tumor necrosis factor ligand superfamily member 13,18492,70,0.60 [0.37-0.99],0.0458172626144999
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,18632,72,0.45 [0.30-0.67],9.05595920053646e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFSF8,Tumor necrosis factor ligand superfamily member 8,16018,64,3.71 [2.50-5.51],6.821748943269124e-11
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNIP1,TNFAIP3-interacting protein 1,15980,64,1.62 [1.28-2.06],7.575654525572106e-05
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TOP2B,DNA topoisomerase 2-beta,15528,61,1.99 [1.56-2.53],2.1400336084182847e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TOR1AIP1,Torsin-1A-interacting protein 1,15560,59,1.44 [1.03-2.03],0.0347609156194765
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TP53,Cellular tumor antigen p53,18014,68,2.25 [1.77-2.86],2.787892943386265e-11
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TP53BP1,TP53-binding protein 1,15528,61,1.94 [1.52-2.48],9.63310967228617e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TPBGL,Trophoblast glycoprotein-like,15599,60,0.40 [0.18-0.88],0.0232993801241962
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TPK1,Thiamin pyrophosphokinase 1,16007,62,4.63 [2.11-10.13],0.0001259239693597
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TPR,Nucleoprotein TPR,15485,61,1.68 [1.38-2.06],3.569211040309483e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TRAF3,"TNF receptor-associated factor 3, Isoform 2",15528,61,2.06 [1.50-2.83],8.347512120399166e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TREML2,Trem-like transcript 2 protein,18432,70,9.44 [6.47-13.75],1.6406427983251878e-31
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TRIM24,Transcription intermediary factor 1-alpha,15704,62,1.52 [1.12-2.05],0.0071905382839068
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,15956,64,1.28 [1.03-1.60],0.0273718641367242
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TXLNA,Alpha-taxilin,18284,71,1.39 [1.09-1.77],0.007570277688478
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TXN,Thioredoxin,15771,61,1.71 [1.13-2.58],0.0110560594356234
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",UBAC1,Ubiquitin-associated domain-containing protein 1,18344,71,2.07 [1.13-3.81],0.0190574291452491
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ULBP2,UL16-binding protein 2,18284,71,2.39 [1.50-3.80],0.0002301978930305
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",USP25,Ubiquitin carboxyl-terminal hydrolase 25,15951,63,1.48 [1.07-2.06],0.0177037037358031
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",USP28,Ubiquitin carboxyl-terminal hydrolase 28,15980,64,2.24 [1.12-4.46],0.0223803366608055
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VCAM1,Vascular cell adhesion protein 1,18498,69,6.90 [3.75-12.68],5.112902033108282e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VEGFC,Vascular endothelial growth factor C,18477,72,0.61 [0.42-0.89],0.0095408476699302
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VSIG4,V-set and immunoglobulin domain-containing protein 4,18410,70,1.82 [1.14-2.93],0.0129766214499275
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VSNL1,Visinin-like protein 1,15980,64,1.83 [1.14-2.95],0.0129023430087179
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VWA1,von Willebrand factor A domain-containing protein 1,18583,70,1.70 [1.04-2.76],0.0335690712343439
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VWF,von Willebrand factor,18663,72,1.36 [1.03-1.79],0.0301720339624519
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",WARS,"Tryptophan--tRNA ligase, cytoplasmic",18432,70,1.84 [1.07-3.17],0.0275514284121406
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",WFDC2,WAP four-disulfide core domain protein 2,17503,69,1.84 [1.16-2.91],0.0097975769361281
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",18216,70,2.16 [1.35-3.44],0.0012815831795078
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",XCL1,Lymphotactin,18606,70,1.59 [1.20-2.12],0.0014140871743885
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",YAP1,Transcriptional coactivator YAP1,15980,64,2.59 [1.43-4.71],0.0018002904525603
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",YJU2,Splicing factor YJU2,15951,63,3.34 [2.11-5.27],2.560112918218885e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ZBP1,Z-DNA-binding protein 1,15528,61,2.80 [2.16-3.63],8.927538401159256e-15
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ZCCHC8,Zinc finger CCHC domain-containing protein 8,15485,61,1.41 [1.06-1.86],0.0181689341124016
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ZHX2,Zinc fingers and homeoboxes protein 2,15980,64,2.94 [2.50-3.46],3.84070758158628e-39
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ZNRD2,Protein ZNRD2,15956,64,1.76 [1.33-2.33],7.868652045432441e-05
